Observational studyAnnals of hematology2025

Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma.

Antoni Garcia-Guiñon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.